Le Lézard
Classified in: Health, Science and technology
Subjects: Product/Service, Survey

Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils


Therapeutic Solutions International, Inc. (TSOI) announced today a patent filing covering the unanticipated finding that neutrophils, a type of white blood cell, when manufactured in a specific manner, are capable of stopping unwanted immune responses while allowing the body to fight bacteria and viruses.

Classical immunology dogma teaches that these cells act as "first responders" but not as "leader cells", a function which has been classically ascribed to T helper cells.

In a series of experiments, it was found that neutrophils generated from hematopoietic stem cells in the presence of an immunological messenger molecule named IL-10, could potently block rejection responses when these cells were administered in different strains of mice. Importantly the injected cells allow other cells from the same donor to not be rejected, allowing for transplantation of therapeutic cells.

"The data generated potentially could change the way the biotechnology industry approaches the problem of pathologic immune responses. As someone who has spent many years believing and publishing that the most potent tolerogenic cell is the immature dendritic cell. The data disclosed today is truly remarkable," said Dr. Thomas Ichim, Board Member and Co-inventor of the patent filed. "We are especially thankful to Tatiana Lebedeva who came up with the idea to investigate the tolerogenic potential of in vitro generated neutrophils and supported the experiments. The idea that an innate immune system cell whose established role is initiating inflammation could act in a tolerogenic manner was completely out of the box, yet Ms. Lebedeva proved us wrong."

"The data demonstrated that these 'tolerogenic neutrophils' allowed the acceptance of therapeutic cells which reduced pathology in dopamine deficiency within Tay Sachs and Friedrich's Ataxia models," said Dr. James Valmeyer, Chief Medical Officer of the Company.

"Therapeutic Solutions International is focused on product development and concurrently elucidating biological mechanisms of our products, which allow for continuous improvement and credibility in the medical community," said Timothy Dixon, President, and CEO. "Through the hard work of our diverse set of advisors and collaborators we are extremely fortunate to have achieved such a high level of innovation."

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com.


These press releases may also interest you

at 17:45
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...

at 17:44
Non-cash impairment of SEK 11.4 billion to be recorded in the second quarter 2024, relating to the impairment of intangibles mainly attributed to the Vonage acquisitionReflects lower anticipated market growth in some of Vonage's current portfolioThe...

at 17:40
Bayen Group, a leading provider of IT solutions and services, has been nominated for the prestigious Southern California Minority Supplier Development Council (SCMSDC) Supplier of the Year award by Northrop Grumman, a global aerospace and defense...

at 17:25
The global secondary tickets market size is estimated to grow by USD 132.1 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 34.25% during the forecast period. Rising popularity of sports events is driving...

at 17:25
The global electric car rental market size is estimated to grow by USD 18.00 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.68% during the forecast period. Increasing demand for rental cars due...

at 17:20
The global supercomputer market size is estimated to grow by USD 33.45 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 28.54% during the forecast period. Commercial customers increasingly adopting...



News published on and distributed by: